What is happening. High-dose intravenous or oral vitamin C is being studied and used in some critical-care protocols. Because intravenous vancomycin is cleared renally and can be nephrotoxic, very high doses of vitamin C (which is metabolized partly to oxalate and can stress the kidneys, especially in renal impairment) warrant caution when used alongside nephrotoxic antibiotics. Standard dietary or supplemental doses pose no meaningful concern.
Mechanism. Vitamin C is partly metabolized to oxalate, and very high doses can increase oxalate load and theoretically contribute to renal stress; combined with vancomycin-associated nephrotoxicity in susceptible patients, this could be additive. No direct chemical interaction occurs.
Recommendation. Routine vitamin C supplementation at typical doses (up to about 1000 mg/day) is compatible with vancomycin. Avoid sustained gram-level (megadose) vitamin C in patients receiving IV vancomycin who have or are at risk for kidney injury, given the theoretical additive renal/oxalate burden. Maintain hydration and renal monitoring.